Pancreatic cancer is the 11th commonest cancer in the UK, with around 7,800 new diagnosed cases each year (see CRUK CancerStatsRisk factors include age, family history, mutations in the BRCA2 gene, smoking, fatty and sugary diet, obesity and lack of physical activity. It is one of the least treata

read more>>

CHAPEL HILL, NC -- Pancreatic cancer is one of the most challenging tumors to treatIdentifying patients who have more aggressive disease could better inform treatment decisions and predict survival prognosis. A new finding from scientists at UNC Lineberger Comprehensive Cancer Center may helpThe

read more>>

CHICAGO -- NewLink Genetics Corporation today announced positive Phase 2 clinical trial data of its HyperAcute®-Pancreas cancer immunotherapy combined with standard adjuvant chemotherapy in patients with surgically resectable pancreatic cancerThe study results suggest a potentially longer dise

read more>>

THOUSAND OAKS, Calif. -- Amgen (Nasdaq: AMGN) today announced results from a small, randomized, placebo-controlled Phase 2 study indicating that adding AMG 479 to gemcitabine improved overall survival at six months (primary endpoint) and progression-free survival in patients with metastatic The st

read more>>

Grand Rapids, Mich. -- Working with researchers from the University of Michigan and Indiana University, Van Andel Research Institute (VARI) investigators have developed a method that could be used to predict whether pancreatic cysts are benign or are precursors to invasive cancerMore pancreatic cy

read more>>

CHICAGO -- Early trials using targeted monoclonal antibodies in combination with existing therapies show promise in treating pancreatic cancer and metastatic breast cancer, according to research that will be presented by investigators from the University of Pennsylvania's Abramson Cancer Center at

read more>>

CHICAGO, IL. -- Fox Chase Cancer Center investigators find that pancreatic cancer patients who have circulating tumor cells tend to have worse outcomes than patients without circulating tumor cellsAdditionally, the team has uncovered evidence that not all circulating tumor cells are the same, and

read more>>

CHICAGO, IL. -- Cancer of the pancreas––a glandular organ that lies behind the stomach and secretes vital enzymes and hormones––seldom is detected in early stages, making treatment difficult and survival statistics particularly grimHowever, new research from Fox Chase Cance

read more>>

AMES, Iowa -- NewLink Genetics Corporation announced today treatment of the first patient in a nationwide Phase 3 clinical trial of its HyperAcute®-Pancreas cancer immunotherapy for patients who have successfully undergone pancreatic surgical resection"This pivotal study represents one of the

read more>>

SAN MARINO, Calif., May 24 /PRNewswire/ -- Epeius Biotechnologies Corporation (www.epeiusbiotech.com) today announces the results of the clinical study entitled "Phase I and II Studies of Intravenous Rexin-G as Monotherapy for Gemcitabine-resistant Metastatic Pancreas Cancer" at the ASCO Annual ST

read more>>